We've found
8,265
archived clinical trials in
Rheumatoid Arthritis
We've found
8,265
archived clinical trials in
Rheumatoid Arthritis
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Methotrexate-Inadequate Response Study
Updated: 11/5/2015
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Click here to add this to my saved trials